{"id":"NCT01964352","sponsor":"Boehringer Ingelheim","briefTitle":"Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)","officialTitle":"A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2014-10","completion":"2014-11","firstPosted":"2013-10-17","resultsPosted":"2015-11-25","lastUpdate":"2015-11-25"},"enrollment":813,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"tiotropium","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"olodaterol","otherNames":[]},{"type":"DRUG","name":"tiotropium","otherNames":[]},{"type":"DRUG","name":"tiotropium","otherNames":[]},{"type":"DRUG","name":"olodaterol","otherNames":[]}],"arms":[{"label":"tiotropium + olodaterol low dose","type":"EXPERIMENTAL"},{"label":"tiotropium + olodaterol high dose","type":"EXPERIMENTAL"},{"label":"tiotropium","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to assess the efficacy and safety of 12 weeks once daily treatment with orally inhaled tiotropium + olodaterol FDC (delivered by the Respimat inhaler) compared with tiotropium and placebo in patients with COPD.","primaryOutcome":{"measure":"FEV1 AUC0-3h Response","timeFrame":"baseline and 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":-0.014,"sd":0.014},{"arm":"Tiotropium 5 μg","deltaMin":0.205,"sd":0.013},{"arm":"Tiotropium 2.5 μg+ Olodaterol 5 μg","deltaMin":0.285,"sd":0.013},{"arm":"Tiotropium 5 μg + Olodaterol 5 μg","deltaMin":0.316,"sd":0.013}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"0.0872"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":77,"countries":["United States","Belgium","Canada","Czechia","Denmark","Finland","Germany","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["32671684","32462607","27316465","26320402"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":204},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis"]}}